Addition of recombinant human growth hormone to in vitro maturation medium of bovine oocytes.
The aim of this study was to increase the bovine embryonic development rate, adding recombinant human growth hormone (rhGH) to maturation medium of bovine oocytes. Oocytes were matured for 24 h in TCM 199 Earle's salts and five treatments were developed: T1, 0.01 IU/ml of recombinant human follicle stimulating hormone (rhFSH); T2, 0.01 IU/ml of rhFSH + 100 ng/ml of rhGH; T3, 0.01 IU/ml of rhFSH + 1000 ng/ml of rhGH; T4, 100 ng/ml of rhGH; and T5, 1000 ng/ml of rhGH at 39 degrees C and 5% of CO(2) in air and saturated humidity. In vitro fertilization from cumulus-oocyte complexes was conducted in TALP-Fert medium (18-22 h) and spermatozoa were selected by Percoll gradient. Zygotes were incubated in SOFaaci medium in 5% of CO(2) in air, 5% of O(2) at 39 degrees C and saturated humidity for 11 days. There was no statistical difference in cleavage rate and embryo production on day 7 and day 9 among treatments. However, the hatching rate increased significantly in the T4 and T5 treatments (11.0 and 12.8%, respectively), compared with the T1 treatment (4.6%) (p < 0.05). Therefore, the rhGH addition to the oocyte maturation medium showed beneficial effects on the hatching rate of in vitro-produced bovine embryos.
Pozzobon
S E
SE
Department of Veterinarian Clinic and Surgery, Veterinary School of the University of Minas Gerais, Belo Horizonte-MG, Brazil.
Lagares
M A
MA
Brum
D S
DS
Leivas
F G
FG
Rubin
M I B
MI
D000818:Animals; D002417:Cattle; D003470:Culture Media / Q000494:pharmacology; D005260:Female; D005307:Fertilization in Vitro / Q000662:veterinary*; D019382:Human Growth Hormone / Q000494:pharmacology*; D006801:Humans; D009865:Oocytes / Q000187:drug effects* / Q000254:growth & development; D011247:Pregnancy; D011994:Recombinant Proteins / Q000494:pharmacology
D003470:Culture Media; D011994:Recombinant Proteins; D019382:Human Growth Hormone